SBRA
BEARISH
$20.68
Live
Sabra Health Care REIT, Inc. · NASDAQ
Target $22.0
(+6.4%)
$17.04
52W Range
$21.07
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 19, 2026
Market cap
$5.21B
P/E
32.31
ROE
5.6%
Profit margin
20.1%
Debt/Equity
0.9
Dividend yield
5.8%
AI Analysis
AI-powered fundamental assessment
Confidence
85%
SBRA presents a precarious financial profile with a Piotroski F-Score of 4/9, indicating only stable, non-strong health. The stock is trading at a severe premium to both its Graham Number ($12.71) and Intrinsic Value ($4.48), while maintaining a dangerous dividend payout ratio of 187.5%. Despite double-digit revenue growth, the company is experiencing a sharp contraction in earnings (-44.7% YoY), suggesting a fundamental disconnect between top-line growth and profitability. The combination of bearish technicals, negative insider sentiment, and unsustainable dividends suggests a value trap despite optimistic analyst targets.
Key Strengths
Strong revenue growth (15.8% YoY)
High gross margins (65.19%)
Manageable Debt/Equity ratio (0.90) compared to sector average
Strong long-term price appreciation (5Y Change +73.9%)
Healthy current ratio (1.80) providing short-term liquidity
Key Risks
Unsustainable dividend payout ratio (187.5%)
Severe earnings collapse (-44.7% YoY)
Significant overvaluation relative to Graham and Intrinsic values
Bearish technical trend (10/100) and insider sentiment (30/100)
Poor earnings track record with frequent misses over the last 25 quarters
AI Fair Value Estimate
Based on comprehensive analysis
$12.71
-38.5% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
38
Weak
25
40
60
50
15
AI Verdict
Overvalued Value Trap
Key drivers: Unsustainable payout ratio, Earnings contraction, Price-to-Intrinsic gap
Confidence
90%
Value
25/100
Ref P/E, PEG, Graham Number
Positives
No standout positives identified.
Watchpoints
- P/E of 32.31 is high for the growth profile
- PEG ratio of 5.28 indicates extreme overvaluation
- Price is 62% higher than Graham Number
Future
40/100
Ref Growth rates
Positives
- Consistent revenue growth (>15%)
Watchpoints
- Earnings growth is deeply negative (-44.7%)
- Negative Q/Q earnings progression
Past
60/100
Ref Historical trends
Positives
- Strong 3Y and 5Y price returns
Watchpoints
- History of significant earnings misses (e.g., 2023-02-21)
Health
50/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Debt/Equity (0.90) is lower than sector average (2.46)
Watchpoints
- Piotroski F-Score of 4/9 is mediocre
Dividend
15/100
Ref Yield, Payout
Positives
- Attractive yield of 5.8%
Watchpoints
- Payout ratio of 187.5% indicates the dividend is not covered by earnings
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$20.68
Analyst Target
$22.0
Upside/Downside
+6.4%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for SBRA and closest competitors.
Updated 2026-04-17
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
SBRA
Sabra Health Care REIT, Inc.
Primary
|
+73.9% | +131.3% | +21.6% | +17.7% | +0.2% | +1.1% |
|
PECO
Phillips Edison & Company, Inc.
Peer
|
+695.5% | +36.7% | +13.4% | +16.3% | +2.7% | +1.0% |
|
CIGI
Colliers International Group Inc.
Peer
|
+6.7% | +10.1% | -2.1% | -28.9% | -8.4% | +1.1% |
|
OPEN
Opendoor Technologies Inc.
Peer
|
-73.8% | +175.4% | +426.2% | -34.7% | -7.0% | +3.9% |
|
NMRK
Newmark Group, Inc.
Peer
|
+56.5% | +153.0% | +48.1% | -11.9% | +9.1% | +7.4% |
SBR
Sabra Health Care REIT, Inc.
Primary
5Y
+73.9%
3Y
+131.3%
1Y
+21.6%
6M
+17.7%
1M
+0.2%
1W
+1.1%
PEC
Phillips Edison & Company, Inc.
Peer
5Y
+695.5%
3Y
+36.7%
1Y
+13.4%
6M
+16.3%
1M
+2.7%
1W
+1.0%
CIG
Colliers International Group Inc.
Peer
5Y
+6.7%
3Y
+10.1%
1Y
-2.1%
6M
-28.9%
1M
-8.4%
1W
+1.1%
OPE
Opendoor Technologies Inc.
Peer
5Y
-73.8%
3Y
+175.4%
1Y
+426.2%
6M
-34.7%
1M
-7.0%
1W
+3.9%
NMR
Newmark Group, Inc.
Peer
5Y
+56.5%
3Y
+153.0%
1Y
+48.1%
6M
-11.9%
1M
+9.1%
1W
+7.4%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
32.31
Forward P/E
26.34
PEG Ratio
5.28
P/B Ratio
1.84
P/S Ratio
6.72
EV/Revenue
9.9
EV/EBITDA
17.18
Market Cap
$5.21B
Profitability
Profit margins and return metrics
Profit Margin
20.06%
Operating Margin
23.7%
Gross Margin
65.19%
ROE
5.59%
ROA
3.07%
Growth
Revenue and earnings growth rates
Revenue Growth
+15.8%
Earnings Growth
-44.7%
Q/Q Revenue Growth
+16.21%
Q/Q Earnings Growth
-41.7%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.9
Moderate
Current Ratio
1.8
Good
Quick Ratio
1.47
Good
Cash/Share
$0.3
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$0.2B
Gross Margin
62.0%
Op. Margin
30.5%
Net Margin
12.8%
Total Assets
$5.5B
Liabilities
$2.7B
Equity
$2.8B
Debt/Equity
0.95x
Operating CF
$0.1B
Free Cash Flow
$0.1B
FCF Yield
100%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-04-29
$N/A
2026-02-12
$0.16
-0.5% surprise
2025-11-05
$0.17
-5.8% surprise
2025-08-04
$0.25
+45.2% surprise
Real Estate Sector Comparison
Comparing SBRA against 101 companies in the Real Estate sector
(5 bullish, 17 neutral, 79 bearish)
P/E Ratio
32.31
This Stock
vs
41.18
Sector Avg
-21.5%
(Discount)
Return on Equity (ROE)
5.59%
This Stock
vs
-56.48%
Sector Avg
-109.9%
(Below Avg)
Profit Margin
20.06%
This Stock
vs
10.28%
Sector Avg
+95.2%
(Superior)
Debt to Equity
0.9
This Stock
vs
2.41
Sector Avg
-62.6%
(Less Debt)
Revenue Growth
15.8%
This Stock
vs
27019.31%
Sector Avg
-99.9%
(Slower)
Current Ratio
1.8
This Stock
vs
6.29
Sector Avg
-71.3%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
SBRA
Sabra Health Care REIT, Inc.
|
BEARISH | $5.21B | 32.31 | 5.6% | 20.1% | $20.68 | |
|
PECO
Phillips Edison & Company, Inc.
|
BEARISH | $5.39B | 43.67 | 4.7% | 15.3% | $38.87 | Compare |
|
CIGI
Colliers International Group Inc.
|
BEARISH | $5.52B | 53.49 | 8.5% | 1.9% | $108.06 | Compare |
|
OPEN
Opendoor Technologies Inc.
|
BEARISH | $4.62B | - | -151.3% | -29.7% | $4.82 | Compare |
|
NMRK
Newmark Group, Inc.
|
BULLISH | $4.03B | 23.13 | 9.4% | 3.8% | $15.73 | Compare |
SBRA
Sabra Health...
BEARISH
Mkt Cap
$5.2B
P/E
32.3
ROE
5.6%
Price
$20.68
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-25 | FLORES JESSICA | Officer | Sale | 15,231 | $302,488 |
| 2026-02-27 | BARBAROSH CRAIG A | Director | Stock Award | 781 | - |
| 2026-02-27 | MALEHORN JEFFREY A | Director | Stock Award | 781 | - |
| 2026-02-27 | KATZMANN LYNNE S. | Director | Stock Award | 781 | - |
| 2026-02-27 | MATROS RICHARD K | Chief Executive Officer | Stock Award | 13,358 | - |
| 2026-02-27 | KONO ANN | Director | Stock Award | 781 | - |
| 2026-02-27 | COSTA MICHAEL LOURENCO | Chief Financial Officer | Stock Award | 4,005 | - |
| 2026-02-27 | CUSACK CATHERINE | Director | Stock Award | 781 | - |
| 2026-02-27 | FLORES JESSICA | Officer | Stock Award | 368 | - |
| 2026-02-27 | SMITH DARRIN | Chief Investment Officer | Stock Award | 478 | - |
| 2026-02-27 | FOSTER MICHAEL JEFFREY | Director | Stock Award | 781 | - |
| 2026-02-10 | MATROS RICHARD K | Chief Executive Officer | Stock Award | 85,160 | - |
| 2026-02-10 | COSTA MICHAEL LOURENCO | Chief Financial Officer | Stock Award | 22,848 | - |
| 2026-02-10 | FLORES JESSICA | Officer | Stock Award | 3,198 | - |
| 2026-02-10 | SMITH DARRIN | Chief Investment Officer | Stock Award | 19,571 | - |
FLORES JESSICA
Officer
2026-03-25
15,231 shares
·
$302,488
BARBAROSH CRAIG A
Director
2026-02-27
781 shares
MALEHORN JEFFREY A
Director
2026-02-27
781 shares
KATZMANN LYNNE S.
Director
2026-02-27
781 shares
MATROS RICHARD K
Chief Executive Officer
2026-02-27
13,358 shares
KONO ANN
Director
2026-02-27
781 shares
COSTA MICHAEL LOURENCO
Chief Financial Officer
2026-02-27
4,005 shares
CUSACK CATHERINE
Director
2026-02-27
781 shares
FLORES JESSICA
Officer
2026-02-27
368 shares
SMITH DARRIN
Chief Investment Officer
2026-02-27
478 shares
FOSTER MICHAEL JEFFREY
Director
2026-02-27
781 shares
MATROS RICHARD K
Chief Executive Officer
2026-02-10
85,160 shares
COSTA MICHAEL LOURENCO
Chief Financial Officer
2026-02-10
22,848 shares
FLORES JESSICA
Officer
2026-02-10
3,198 shares
SMITH DARRIN
Chief Investment Officer
2026-02-10
19,571 shares
Insider transactions can signal confidence or concerns about company prospects
SEC Filings
Recent regulatory filings from the SEC EDGAR database
8-K
10-K
10-Q
8-K
8-K
10-Q
8-K
8-K
8-K
Data sourced from SEC EDGAR. AI summaries generated automatically.
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
13 analysts
Wells Fargo
2026-03-26
Overweight
Overweight
Truist Securities
2026-03-13
Hold
Hold
Scotiabank
2026-03-02
Sector Perform
Sector Perform
UBS
2026-02-19
Neutral
Neutral
Citigroup
2026-02-18
Buy
Buy
Citizens
2026-02-18
Market Outperform
Market Outperform
Cantor Fitzgerald
2026-02-17
Neutral
Neutral
Truist Securities
2026-01-20
Hold
Hold
Wells Fargo
2025-11-25
Overweight
Overweight
UBS
2025-11-18
Neutral
Past News Coverage
Recent headlines mentioning SBRA from our newsroom.
Newest → oldest
No matching news yet.